PharVision Advisers’s United Community Banks UCB Stock Holding History

PharVision Advisers’s Portfolio UCB Stock Details UCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,399	Closed	-$262K	–	677
2025 Q4	$262K	Buy	+8,399	New	+$259K	0.13%	361

Other funds holding UCB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PharVision Advisers's UCB Position: Q1 2026 in Review

PharVision Advisers sold out of United Community Banks (UCB) in Q1 2026, closing a stake of 8,399 shares — an estimated $262K sold.

PharVision Advisers first reported a position in UCB in Q4 2025 and held it in 1 quarter. The position peaked at $262K in Q4 2025. 354 funds tracked by Wall St. Rank hold UCB as of Q1 2026.

PharVision Advisers reported no remaining United Community Banks position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 8,399 United Community Banks shares in Q1 2026, an estimated $262K.
PharVision Advisers first reported a position in United Community Banks in Q4 2025 and held it in 1 quarter.
PharVision Advisers's United Community Banks position peaked at $262K in Q4 2025.
354 funds tracked by Wall St. Rank held United Community Banks as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.